About Us
-
Tse, Theresa Y YExecutive Director and Chairwoman- is the chairwoman of the Board, an executive director, and the chairwoman of the executive board committee and the nomination committee of Sino Biopharmaceutical Co., Ltd. since 2015. In 2017, she served as the director of CT Tianqing and the vice chairwoman of Beijing Tide, and a member of the first and second board of directors of Beijing Chia Tai Charity Foundation. Ms. Tse has a Bachelor of Science Degree in economics from the Wharton School of business at the University of Pennsylvania. She focused on the study of financial and health management. As a new generation business leader, Ms. Tse was recognised as one of the“Most Outstanding Business Women in China” by Forbes China online in 2018 and 2019.
-
Tse, Eric S YChief Executive Officer- is an executive director, a member of the executive board committee and the Chief Executive Officer of the Company and the president of CT Tianqing. He holds a Bachelor of Science degree in Economics from the Wharton School of the University of Pennsylvania and a master degree in Management and Global Leadership from Schwarzman College, Tsinghua University. Before joining the Company in June 2018, Mr. Tse, Eric S Y served as the chief executive officer of Liepin North America, a reputable human resources company. Mr. Tse, Eric S Y founded the Penn Wharton China Summit during his time at university, and established the China Summit Foundation at the end of 2016. He was awarded the “Top Ten Outstanding Chinese American Youth” in 2018 (the list of which was jointly selected by the All America Chinese Youth Federation, the American Chinese Public Diplomacy Association, and the English “Los Angeles Post”).
-
Tse HsinExecutive Director- is an executive director and a vice president of the Company. He is mainly responsible for the acquisition and merger activities of the Group. He is also the Group’s spokesman. Mr. Tse Hsin graduated from the University of Hong Kong with a Bachelor’s Degree (Honors) in Industrial Engineering. He joined the Group in August, 1995 as an assistant to the president of the Company and served as the general manager of Xian C.P. Pharmaceutical Co., Ltd. Mr. Tse Hsin was a council member of the first council and the executive council member of the second council of Chaozhou Natives Chamber of Commerce Beijing. He is also an executive member of the Right Protection Association for the Medical Treatment Equipment Enterprises of the Shaanxi Province, the vice chairman of the fourth council of the Foreign Invested Enterprises Association of the Shaanxi Province, the executive member of the third committee of the Shaanxi Cancer Fighting Association and the vice chairman of the World Chinese Medicine and Pharmaceutical Professional Joint Committee. He was awarded the “Outstanding Management Award for Foreign-invested Enterprises of Shaanxi Province” by the Shaanxi Provincial Government and the “Outstanding entrepreneur who cares about his staff” by the Shaanxi Foreign Invested Enterprises Association. He was a director of CT Tianqin and Beijing Tide, and is currently a director of NJCTT and CP Qingdao, a supervisor of CT Tianqing, and the president of Chia Tai Shaoyang Orthopedic Hospital.
-
Ben ToogoodCEO of invoX /Head of Globalization- 23 years experience in the pharmaceutical industry, the last 14 years leading business development roles in Europe, US, and Canada. Formerly Novartis, Aspen, and Pharmathen.
-
Chen,SeanChief Strategy Officer- Former General Manager of respiratory, immunology and GI units of AstraZeneca China;Former Head of BD & corporate strategy of Takeda China;Worked at Novartis and McKinsey;MD, Kaohsiung Medical University; MBA, INSEAD
-
Li ChunlingChief Financial Officer- Graduated from Guizhou University of Finance and Economics, she is a senior accountant with the qualification of Certified Public Accountant. She worked in an accounting firm and joined the Group in 1996. Ms. Li has more than 20 years of work experience in finance and audit, and more than 10 years of work experience in information work.
-
Jin SongVice president- The group's vice president is responsible for the group's public affairs and ESG related work. Mr. Jin graduated from China Pharmaceutical University with a bachelor's degree in pharmaceutical preparation and a master's degree in international cooperation policy in public health management from Ritsumeikan University in Japan. Before joining the company, he held the position of vice president in China's large pharmaceutical central enterprise group, and had worked in the national pharmaceutical management department, with more than 20 years of management experience in the pharmaceutical industry.
-
George OrphanidesChief Scientific Advisor, invoX- Twenty years of experience in small molecule and biological drug development in the pharmaceutical industry, working across preclinical and clinical stages. Twelve years in senior leadership roles at AstraZeneca, including head of global disease area teams.